CDMRP – Rare Cancers Research Program Resource and Community Development Award
Ends on 1 July 2025
The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical data sets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Engagement and partnerships with Patient Advocates must be integrated into the project from development of the research question through the execution of the study. Community building and enhancement are key components. Dissemination and sustainability of the platform for scientific and/or clinical, and patient community must be described.